YBLi006-AHomo sapiens (Human)Induced pluripotent stem cell

Also known as: YBL/PH/2022/0025

AI Summary

No AI-generated summary available for this cell line.

Basic Information

Database IDCVCL_D0QA
SpeciesHomo sapiens (Human)
Tissue SourcePeripheral blood[UBERON:UBERON_0000178]

Disease Information

DiseaseHereditary breast cancer

DepMap Information

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleFANCIp.Cys742Ser (c.2225G>C)Heterozygous-PubMed=37290137
MutationSimpleFANCIp.Ala86Val (c.257C>T)Heterozygous-PubMed=37290137
MutationSimpleFANCIp.Gly27Val (c.80G>T)Heterozygous-PubMed=37290137
MutationSimpleBRCA1p.Ser1613Gly (c.4837A>G)Heterozygous-PubMed=37290137
MutationSimpleBRCA1p.Lys1183Arg (c.3548A>G)Heterozygous-PubMed=37290137
MutationSimpleBRCA1p.Glu1038Gly (c.3113A>G)Heterozygous-PubMed=37290137
MutationSimpleBRCA1p.Pro871Leu (c.2612C>T)Heterozygous-PubMed=37290137

Publications

Derivation of breast cancer patient derived human induced pluripotent stem cell line (YBLi006-A) with FANC-BRCA gene mutations: a resource for precision & personalized medicine.

Chitrangi S., Vaity P., Jamdar A., Sarkar J., Bhatt S.

Stem Cell Res. 70:103128-103128(2023).